Skip to main content
. Author manuscript; available in PMC: 2013 Apr 3.
Published in final edited form as: Arch Pediatr Adolesc Med. 2012 Nov 1;166(11):1030–1036. doi: 10.1001/archpediatrics.2012.1263

Table 2.

Comparison of Prevalence MetSHOMA and MetSIFG by Gender and Weight Group

MetSHOMA MetSIFG
Male
(n=538)
Female
(n=647)
Total
(n=1185)
Male
(n=538)
Female
(n=647)
Total
(n=1185)
Total (%)a 94 (7.5%) 85 (13.1%) 179 (15.1%) 66 (12.3%) 46 (7.1%) 112 (9.5%)

Healthy Weight (%) 0 (0%) 1 (1.5%) 1 (0.3%) 0 (0%) 1 (0.5%) 1 (0.3%)
Overweight (%)a 9 (6.0%) 14 (5.9%) 23 (5.9%) 4 (2.7%) 6 (2.5%) 10 (2.6%)
Obese (%)a 85 (35.9%) 70 (34.1%) 155 (35.1%) 62 (26.2%) 39 (19.0%) 101 (22.9%)
a

Indicates significant differences in prevalence between MetSHOMA and MetSIFG for total and gender groups separately.